semaglutide tablets for weight loss dose dosage chart in units Dosing & Prescribing | RYBELSUS®

GLP-1 receptor agonist therapy uses medications that mimic the natural GLP-1 hormone to reduce appetite, slow digestion, and target visceral belly fat

The Lancet Gastroenterology Hepatology

Clinical trials show tirzepatide produces 22.5% average weight loss compared to semaglutides 14.9%, likely because activating both incretin pathways provides more comprehensive metabolic regulation than activating one pathway alone

Facial exercises may also contribute to improved muscle tone in the face, while cardiovascular workouts can enhance circulation, delivering nutrients to the skin and helping maintain a youthful glow during weight loss

: